Anti-oncogenic role of the endoplasmic reticulum differentially activated by mutations in the MAPK pathway.
about
Melanoma: from melanocyte to genetic alterations and clinical optionsSkp2 targeting suppresses tumorigenesis by Arf-p53-independent cellular senescenceRemodeling of chromatin structure in senescent cells and its potential impact on tumor suppression and agingThe thioxotriazole copper(II) complex A0 induces endoplasmic reticulum stress and paraptotic death in human cancer cells"Inflammaging" as a Druggable Target: A Senescence-Associated Secretory Phenotype-Centered View of Type 2 DiabetesCancer Microenvironment and Endoplasmic Reticulum Stress ResponseHuman UBN1 is an ortholog of yeast Hpc2p and has an essential role in the HIRA/ASF1a chromatin-remodeling pathway in senescent cells.TMEM33: a new stress-inducible endoplasmic reticulum transmembrane protein and modulator of the unfolded protein response signalingCharacterization of a Steroid Receptor Coactivator Small Molecule Stimulator that Overstimulates Cancer Cells and Leads to Cell Stress and DeathPERK Integrates Oncogenic Signaling and Cell Survival During Cancer DevelopmentKaposi's sarcoma-associated herpesvirus K7 induces viral G protein-coupled receptor degradation and reduces its tumorigenicityInduction of premature senescence by hsp90 inhibition in small cell lung cancerRPLP1, a crucial ribosomal protein for embryonic development of the nervous systemTumorigenic and Immunosuppressive Effects of Endoplasmic Reticulum Stress in CancerPrinciples of cancer therapy: oncogene and non-oncogene addictionAGR2 is a novel surface antigen that promotes the dissemination of pancreatic cancer cells through regulation of cathepsins B and DRAB7 counteracts PI3K-driven macropinocytosis activated at early stages of melanoma developmentLineage-specific roles of the cytoplasmic polyadenylation factor CPEB4 in the regulation of melanoma drivers.A stromal gene signature associated with inflammatory breast cancer.Suppression of the DHX9 helicase induces premature senescence in human diploid fibroblasts in a p53-dependent manner.Inhibition of proliferation by PERK regulates mammary acinar morphogenesis and tumor formation.Ras, an actor on many stages: posttranslational modifications, localization, and site-specified events.Inhibition of eIF2alpha dephosphorylation inhibits ErbB2-induced deregulation of mammary acinar morphogenesisThe relative contributions of the p53 and pRb pathways in oncogene-induced melanocyte senescence.Dormancy of metastatic melanomaNew biomarkers probing depth of cell senescence assessed by laser scanning cytometry.SNIPER(TACC3) induces cytoplasmic vacuolization and sensitizes cancer cells to Bortezomib.The nuclear receptor peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) promotes oncogene-induced cellular senescence through repression of endoplasmic reticulum stress.PERK promotes cancer cell proliferation and tumor growth by limiting oxidative DNA damageOncogenic stress induced by acute hyper-activation of Bcr-Abl leads to cell death upon induction of excessive aerobic glycolysis.Combining the endoplasmic reticulum stress-inducing agents bortezomib and fenretinide as a novel therapeutic strategy for metastatic melanomaIncreasing melanoma cell death using inhibitors of protein disulfide isomerases to abrogate survival responses to endoplasmic reticulum stress.Raf/MEK/ERK can regulate cellular levels of LC3B and SQSTM1/p62 at expression levelsAbrogation of BRAFV600E-induced senescence by PI3K pathway activation contributes to melanomagenesis.The essence of senescence.Differential sensitization of different prostate cancer cells to apoptosis.Ubiquitination of inositol-requiring enzyme 1 (IRE1) by the E3 ligase CHIP mediates the IRE1/TRAF2/JNK pathway.A high-content screening assay for small-molecule modulators of oncogene-induced senescence.Melanoma proliferation and chemoresistance controlled by the DEK oncogeneAntagonistic TSC22D1 variants control BRAF(E600)-induced senescence.
P2860
Q21284811-81584F8E-890E-4FFD-9890-E5459872C31DQ24627126-C1CE3ECD-7402-48D4-BFCB-A0130D3C261DQ24642706-E2001FF5-EB45-4FAC-9B3C-9473A965E83FQ24651419-BA1869CC-07FD-4CB8-8701-E3FA024E019CQ26747251-1D941860-C625-4DAD-BF8D-7DCD2D5B54ADQ26778533-741A6C42-1768-4BAD-A811-7379711F0596Q27934187-2C2DF24F-C505-40C4-B90E-865923704752Q28115071-5D9D08E7-2082-47D2-B7AF-6E953865770CQ28119116-7A998208-7646-415B-B0C7-B402730E22EFQ28397172-377D239E-784B-407D-8873-46A9FF23C304Q28473623-35BDE71D-8619-456F-BA0D-D9F3102EBFECQ28474354-ACE899EA-87CB-4E2E-875D-285B824F8E8CQ28589114-36792611-CBBF-4FB6-9AA2-CDFAFC579891Q29248711-F0D22385-0A7D-4100-9825-06DECBF33A12Q29616779-8BC5184C-3828-4273-B4EF-0CC45FD37020Q30532006-CE1AA0D0-3FB6-499D-A1FD-64E7160A5CB2Q30657002-9EC5244C-27FB-4A8E-8B89-AE65917D6C0BQ30829456-F94861BE-2A8D-4F64-8740-FA1E39202481Q30838525-C7E2D739-6484-40F0-9E9A-15A112548EA9Q33112680-E4893953-B6B4-41FF-8150-CE65A7C0EF5CQ33291107-00EA20C2-C36F-4E3F-8BB6-C61AA356E74BQ33351823-25DF12A9-665D-457A-A800-D45D2D35E9CBQ33503420-5C9904EC-82AF-402E-BF74-A0CC9B97D045Q33588743-A7DCB7C8-F0C2-433A-AE77-2EDB6E35D376Q33649569-E4D27FC9-0D0A-4F95-9849-D79A819A58DFQ33715537-4979665D-E2F3-4B2A-A50D-AEF7B445D43DQ33738889-1D1CD0E3-1BC2-476A-B148-BD35EF1C84EBQ33931176-7939513D-39D3-4120-89B9-148EC1B9A6A2Q33977034-D9795A4D-73B8-48DB-AB5E-0B74E84E4CD5Q34031967-1D22B54B-6057-4C35-85D2-BC725ED26032Q34051168-4576FADF-57F4-4999-B08E-9C1D231DC0D8Q34051194-3D88CF5E-2F4E-4576-B664-7BAF61A0A9E3Q34183909-FA738BC4-D2D7-42AD-A69E-F8990596CC24Q34253185-76B7CD5D-C690-44B1-9B49-43FAE1A2D80EQ34288983-9317179F-1F24-4466-B702-D9AF00E76584Q34370353-3B6E9CAC-2C71-4087-B7C3-98044F0BE9D8Q34431021-EE8540E6-A198-4150-BEB8-6D8049F08DA6Q34755077-CC7DAE22-8C72-4D4F-A27A-7F709F807B01Q34997265-AA2C278E-84C8-4502-B7F7-9807479711D1Q35007125-6C01C944-63D9-4679-9C17-C805A799B8AE
P2860
Anti-oncogenic role of the endoplasmic reticulum differentially activated by mutations in the MAPK pathway.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Anti-oncogenic role of the end ...... mutations in the MAPK pathway.
@en
Anti-oncogenic role of the end ...... mutations in the MAPK pathway.
@nl
type
label
Anti-oncogenic role of the end ...... mutations in the MAPK pathway.
@en
Anti-oncogenic role of the end ...... mutations in the MAPK pathway.
@nl
prefLabel
Anti-oncogenic role of the end ...... mutations in the MAPK pathway.
@en
Anti-oncogenic role of the end ...... mutations in the MAPK pathway.
@nl
P2093
P2860
P356
P1433
P1476
Anti-oncogenic role of the end ...... mutations in the MAPK pathway.
@en
P2093
Christophe Denoyelle
Douglas R Fullen
George Abou-Rjaily
Jenny N Pointer
Lyndon D Su
Mikhail A Nikiforov
Monique Verhaegen
Randal J Kaufman
Stephen B Gruber
Timothy M Johnson
P2860
P2888
P304
P356
10.1038/NCB1471
P577
2006-09-10T00:00:00Z